Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
Status: Open
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Tuesday, October 10, 2028 - check the notice for the exact time
- Opened Nov 3, 2026
- Amount
- Up to $2.5M
- Expected awards: 3
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- Documents with the official notice: RFA-NS-28-012-Full-Announcement.html
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.866, 93.NS1
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
This Notice of Funding Opportunity (NOFO) supports the translation of genome editing and other biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). The program spans the full translational pipeline, from therapeutic lead optimization and drug product development through ...